Ebola outbreak: What is ZMapp and could the experimental treatment stop the disease?

More than 1,000 people have died so far in the outbreak in West Africa

Liberian doctors are set to be the first Africans to receive an experimental Ebola treatment, ZMapp.

Public anger has been growing that the serum, which is in the early stages of development and has not been tested on humans, has only been used to treat Westerners so far.

Two American aid workers and a Spanish missionary priest received the drug and its manufacturer, Mapp Biopharmaceutical, has said its supply is now exhausted.

The announcement came as the World Health Organisation considered ethical questions about who should get access to an experimental drug in an emergency.

There is no proven treatment for Ebola but basic supportive care, like keeping patients hydrated, maintaining their blood pressure and treating any infections can make a difference in survival.

The Ebola outbreak has so far killed more than 1,000 people in Sierra Leone, Liberia, Guinea and Nigeria and ZMapp is one of several drugs in development to attempt to stop its spread.

Video: Liberians resent restricted movement as result of virus

Q: What is this drug?

A: Called ZMapp, it is a cocktail of specially engineered antibodies designed to target and inactivate the Ebola virus.

 

Q: What do we know about whether it works?

A: Very little. Various antibodies have been tested in small numbers of monkeys but not people. In one study, 43 percent of treated monkeys survived when the drug was given after the animals showed symptoms.

 

Q: Why isn't ZMapp being tested more widely to find out if it works in people?

A: There's not enough available. The antibodies are grown inside tobacco plants and then extracted and purified, a slow process. US officials have estimated that only a modest amount could be produced in two or three months, unless some way to speed production is found.

 

Q: What does it mean that the two American aid workers who received the drug are reported to be slowly improving?

A: Top US health officials stress that there's no way to know if the drug really helped, or if those two patients would have been among the 40 percent of people who are surviving this outbreak anyway. Without human studies, there also isn't any way to know if the drug might harm instead of help.

 

Q: How were the Americans and Spanish priest chosen to get some of those limited doses, rather than Africans?

A: The international relief organisation Samaritan's Purse and Emory University Hospital requested that the manufacturer provide some of the drug for the two Americans, and the manufacturer agreed. As for the Spanish missionary priest, it wasn't clear exactly how Spanish officials obtained a dose that apparently was in Geneva. The priest also was infected in Liberia and is in isolation at a Madrid hospital.

 

Q: How is Liberia getting the drug?

A: The U.S. Department of Health and Human Services said it had helped connect Liberia with the manufacturer. “Since the drug was shipped for use outside the US, appropriate export procedures had to be followed,” the statement said.

 

Q: Are any other drugs in the pipeline?

A: Canada's Tekmira Pharmaceuticals Corp is developing a drug that targets Ebola's genetic material. The FDA had halted a small safety study with questions about a reaction in healthy volunteers. Last week, Tekmira announced that FDA had modified its restriction, clearing a roadblock to possible experimental use in infected patients. The company said at the time that it was “carefully evaluating options.”

A handful of other companies are in earlier stages of drug development and a possible vaccine to prevent the disease is expected to begin first-stage safety studies sometime in the autumn.

 

Q: If experimental drugs won't stop the outbreak, what will?

A: Experts say old-fashioned public health measures: rapidly finding and isolating the sick, quarantining those exposed and educating the public on how to avoid the risk of infection. Ebola is spread through direct contact with bodily fluids of sick patients. Two main drivers of the outbreak are thought to be improper infection control during patient care and traditional but risky burial practices that see mourners handling bodies that are still infectious.

AP

Start your day with The Independent, sign up for daily news emails
Have you tried new the Independent Digital Edition apps?
ebooks
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Recruitment Genius: Photographer / Floorplanner / Domestic Energy Assessor

£16000 - £25000 per annum: Recruitment Genius: A Photographer/ Floor planner /...

Ashdown Group: Front-End Developer - Surrey - £40,000

£30000 - £40000 per annum: Ashdown Group: Front-End Developer - Guildford/Craw...

Recruitment Genius: Customer Service Assistant

£13500 - £15000 per annum: Recruitment Genius: A Customer Service Assistant is...

Recruitment Genius: Sales Executive - OTE £35,000

£16000 - £35000 per annum: Recruitment Genius: An ambitious and motivated Sale...

Day In a Page

Not even the 'putrid throat' could stop the Ross Poldark swoon-fest'

Not even the 'putrid throat' could stop the Ross Poldark swoon-fest'

How a costume drama became a Sunday night staple
Miliband promises no stamp duty for first-time buyers as he pushes Tories on housing

Miliband promises no stamp duty for first-time buyers

Labour leader pushes Tories on housing
Aviation history is littered with grand failures - from the the Bristol Brabazon to Concorde - but what went wrong with the SuperJumbo?

Aviation history is littered with grand failures

But what went wrong with the SuperJumbo?
Fear of Putin, Islamists and immigration is giving rise to a new generation of Soviet-style 'iron curtains' right across Europe

Fortress Europe?

Fear of Putin, Islamists and immigration is giving rise to a new generation of 'iron curtains'
Never mind what you're wearing, it's what you're reclining on

Never mind what you're wearing

It's what you're reclining on that matters
General Election 2015: Chuka Umunna on the benefits of immigration, humility – and his leader Ed Miliband

Chuka Umunna: A virus of racism runs through Ukip

The shadow business secretary on the benefits of immigration, humility – and his leader Ed Miliband
Yemen crisis: This exotic war will soon become Europe's problem

Yemen's exotic war will soon affect Europe

Terrorism and boatloads of desperate migrants will be the outcome of the Saudi air campaign, says Patrick Cockburn
Marginal Streets project aims to document voters in the run-up to the General Election

Marginal Streets project documents voters

Independent photographers Joseph Fox and Orlando Gili are uploading two portraits of constituents to their website for each day of the campaign
Game of Thrones: Visit the real-life kingdom of Westeros to see where violent history ends and telly tourism begins

The real-life kingdom of Westeros

Is there something a little uncomfortable about Game of Thrones shooting in Northern Ireland?
How to survive a social-media mauling, by the tough women of Twitter

How to survive a Twitter mauling

Mary Beard, Caroline Criado-Perez, Louise Mensch, Bunny La Roche and Courtney Barrasford reveal how to trounce the trolls
Gallipoli centenary: At dawn, the young remember the young who perished in one of the First World War's bloodiest battles

At dawn, the young remember the young

A century ago, soldiers of the Empire – many no more than boys – spilt on to Gallipoli’s beaches. On this 100th Anzac Day, there are personal, poetic tributes to their sacrifice
Dissent is slowly building against the billions spent on presidential campaigns – even among politicians themselves

Follow the money as never before

Dissent is slowly building against the billions spent on presidential campaigns – even among politicians themselves, reports Rupert Cornwell
Samuel West interview: The actor and director on austerity, unionisation, and not mentioning his famous parents

Samuel West interview

The actor and director on austerity, unionisation, and not mentioning his famous parents
General Election 2015: Imagine if the leading political parties were fashion labels

Imagine if the leading political parties were fashion labels

Fashion editor, Alexander Fury, on what the leaders' appearances tell us about them
Phumzile Mlambo-Ngcuka: Home can be the unsafest place for women

Phumzile Mlambo-Ngcuka: Home can be the unsafest place for women

The architect of the HeForShe movement and head of UN Women on the world's failure to combat domestic violence